med-tech recap preview
investor day meet
cs chicago suppli devic bu tour visit
manag outperform rate cover
topic cours includ mitraclip libr
expect meet focu pipelin deliveri nutrit
final expect meet focu new product launch
margin expans potenti strateg invest
analyst day expect posit expect
least support organ growth year potenti push
rang margin side expect pathway
expect updat well-receiv investor btg deal close
analyst meet also updat
guidanc color growth opportun potenti divestitur
final ncd mean tavr market growth expect
new tavr center expans pick-up center
pace grow year project anoth center
ad smaller tavr center repres smallest segment
 sale project sale segment grow
help drive total sale growth bil
expand tavr market growth posit outperform-weith ew
disrupt ms index ytd bp
bp ltm vs univers
 led group week perform
lead ytd lc ms ntm
ev/ebitda vs vs last week
figur weekli perform suppli devic ms
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
charl martineau pm univers toronto figur upcom event catalyst
intern meet advanc spine techniqu
ticker potenti implic
implic devic trend cardio
addit recent research event contd
robot surgeri survey take-away posit robot especi
hospit volum tracker survey june total respond indic
intend purchas syk mako robot surgeri system next year
approxim respond expect increas robot surgeri relat
spend survey respond expect increas spend total
capit equip view result posit top-pick
well outperform-r underperform-r
fda panel paclitaxel ask cooper label two-day
meet circulatori system devic panel june result fda
recommend new label put place warn physician patient
potenti long-term mortal signal inform decis make panel member also
discuss need cooper ensur appropri time data
collect industri rep outlin next step recommend includ
collabor across investig patient regul industri improv patient
care pad request fda updat march letter convey
total evid avail support benefit-risk profil paclitaxel devic
indic use paclitaxel coat devic account revenu
outperform-r eluvia de pact admir dcb
believ continu uncertainti peripher paclitaxel devic larg
discount stock point
holt weekli analysi attract holt market
impli expect reveal attract holt market
impli expect indic valuat conserv
healthcar subsector med-tech appear fairli price
med-tech recap preview
figur week read research medic suppli devic
bull/bear lunch serv extra bull hold bear
strong finish appreci achiev guid take pressur
ada expert takeaway expert dinner provid addit insight main impact ada
initi tvt takeaway posit ew low-risk tavr uptak increment near-term transform long-
skate puck go commit interoper soft updat ai
ew analysi low-risk tavr deconstruct valuat reinforc confid ew
clean op upsid guid back-end load achiev expect
alc alcon inc initi coverag outperform
june announc afinion dx assay
avail use afinion analyz well afinion
analyz afinion dx assay rapid point-of-car test
clear fda diagnosi diabet assess
patient risk develop condit
fda approv nda
celer
pharmaceut brand name myxredlin myxredlin short-
act human insulin indic improv glycem control adult
pediatr patient diabet mellitu context septemb
enter agreement celer develop certain acut
care gener inject premix oncolyt molecul
oblig purchas individu product right celer
one june announc expans advanc materi
scienc portfolio commerci launch modulu tlif-o
porou titanium implant transforamin lumbar interbodi fusion
devic featur porou surfac technolog base pre-clin
data may provid favor environ bone in-growth on-
growth consist achiev stronger osseointegr solid
implant smooth rough surfac compani also announc
plan launch modulu tlif-a spine implant integr modulu
surfac technolog specif design anterior implant posit
june announc cfo florin retir effect
juli suki upadhyay would replac mr florin zbh cfo mr
florin remain compani advisori capac period
follow success mr upadhyay current serv senior vice
presid global financi oper bristol-my squibb
med-tech recap preview
figur last wk med-tech bp bp bp
med-tech recap preview
figur last month disrupt ms lead ms
disrupt ms index pro-rata weight perform alc ew
base proport revenu driven disrupt technolog
med-tech recap preview
charl martineau pm univers toronto figur last month disrupt ms index outperform smid lc
disrupt ms index pro-rata weight perform ew base proport revenu
driven disrupt technolog
med-tech recap preview
figur ntm ev/ebitda coverag univers
med-tech recap preview
holt market impli expect analysi indic valuat conserv
healthcar subsector holt use revers dcf quantifi market
impli expect calcul futur level return capit cfroi requir
justifi today valuat market impli expect green dot
consensu forecast pink bar indic attract valuat upsid potenti
stock
figur healthcar holt cfroi ntm forecast return capit vs market-impli spread
return capit cfroi histor forecast market impli median industri
current price impli declin return
current price impli increas return
spread forecast vs market impli return capit
note aggreg ex financi regul util reit
med-tech recap preview
charl martineau pm univers toronto market impli expect coverag univers med-tech gener
demand rel sell side forecast holt market impli expect analysi
reveal attract consensu forecast cfroi
market impli expect smid-cap med-tech
figur med-tech holt cfroi ntm forecast return capit vs market-impli spread
return capit cfroi histor forecast market impli
current price impli declin return
current price impli increas return
spread forecast vs market impli return capit
contact inform holt
med-tech recap preview
compani mention price
